Clinical Trials Update:&nbsp;Dec. 23, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.
755619
Six Apart and LiveJournal combine to boast 6.5 million users and a growing business. Also: Microsoft unveils antivirus software.... Canada may stop internet drug sales to America.... and more.
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
594161
Genzyme announces positive study results with a recently acquired drug.
34476
MONDAY, July 2 (HealthDay News) -- New research may someday provide another treatment option for patients battling deadly pancreatic cancer.
519863
The company faces a pivotal clinical trial.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
730807
WASHINGTON - The Food and Drug Administration (news - web sites) will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
121268
EPIX initiates a safety trial and gets good efficacy data.
25097
The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.
25501
(December 29, 2004) - Six clinical studies at the University of Rochester Medical Center have ended because of findings that question the safety of the drugs under investigation.
135618
(National-NBC) Nov. 24, 2004 - The Food and Drug Administration has approved the first drug that specifically targets Multiple Sclerosis.